Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we
Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on
684 words, 9% matched vs 1,329 words, 4% matched Compassion [kuhm–pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by
Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on
Rare disease research is often lacking due to a lack of funding, interest, or awareness. To combat this, the Barth Syndrome Foundation (BSF) and American
According to a story from the Green Bay Press Gazette, the beginning of summer is rapidly approaching and with warming temperatures comes the emergence of
A press release by MYND Sciences announced that the drug research and development company, MYND Life Sciences Inc. has their new intellectual patent for their
According to an article in the Times Union, a group of parents with children who have been diagnosed with rare diseases are leading the crusade
Sobi as well as the Hellenic Institute for the Study of Sepsis have just announced successful results from their SAVE-MORE study for those with COVID-19.
In a recent news release on Morningstar, biopharmaceutical company Albireo Pharma, Inc. (“Albireo”) shared that its investigational drug candidate Bylvay (odevixibat) earned a positive
Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on
Sometimes, medical studies just don’t go the way that companies want them to. According to MedCity News, this is what biotechnology company Larimar Therapeutics
In 2019, generic pharmaceuticals and biosimilars leader Sandoz launched intravenous treprostinil for patients with pulmonary arterial hypertension (PAH). But according to a new media
Cure Rare Disease is a nonprofit organization that aims to help those who are impacted by rare diseases. Currently, the Boston-based company is planning a
© Copyright Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
